Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.

Sung-Chan Gwark,Han Shin Lee,Youngjoo Lee,Sae Byul Lee,Guiyun Sohn,Jisun Kim,Il Yong Chung,Beom Seok Ko,Hee Jeong Kim,Byung Ho Son,Jin-Hee Ahn,Kyung Hae Jung,Sung-Bae Kim,Hee Jin Lee,Gyung-Yub Gong,Sei Hyun Ahn,Jong Won Lee

Annals of surgical oncology（2019）

引用 11|浏览61

暂无评分

摘要

In HR-positive, node-negative MC with tumor size ≥ 3 cm, patients with HER2-positive MC showed worse survival, suggesting a potential role of an anti-HER2 strategy in this subgroup.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要